Utilizing Relatable, participating USPI facilities decreased their overall cost per case and identified immense savings potential across surgical specialties.
As the COVID-19 virus reached its initial peak confirmed case count in April, several states mandated the reduction of elective surgeries not deemed medical necessities. According to data organized on the COVID-19 Dashboard by the Center for Systems Science and!
Relatable Healthcare helps device companies and their reps generate high potential sales leads.
Surgeries in outpatient ambulatory facilities are increasing.
Depending on your role in the healthcare system, your answer may vary.
Current volatility and the upcoming surge and shift in elective surgeries is forcing medical device company leaders to rethink existing business models.
“Flatten the curve” has become the mantra of Covid-19 response resulting in stay-at-home advisories excluding essential travel, social distancing, and postponing elective surgeries.
Bain & Company's research suggests that surgeons at ASCs are more likely to change medical devices than their peers within hospital settings.
Have you or someone you know experienced an antimicrobial resistant infection? The most common is MRSA (methicillin-resistant Staphylococcus aureus), and this type of threatening infection is on the rise nationwide.
Beginning in 2012, average year-over-year hospital costs have grown at a rate exceeding revenue growth. Pressure to maintain healthcare spending continues to intensify and supply chain costs have reached an all-time high.